Your browser doesn't support javascript.
loading
ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism.
Boyle, Sarah Theresa; Poltavets, Valentina; Kular, Jasreen; Pyne, Natasha Theresa; Sandow, Jarrod John; Lewis, Alexander Charles; Murphy, Kendelle Joan; Kolesnikoff, Natasha; Moretti, Paul Andre Bartholomew; Tea, Melinda Nay; Tergaonkar, Vinay; Timpson, Paul; Pitson, Stuart Maxwell; Webb, Andrew Ian; Whitfield, Robert John; Lopez, Angel Francisco; Kochetkova, Marina; Samuel, Michael Susithiran.
Afiliação
  • Boyle ST; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Poltavets V; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Kular J; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Pyne NT; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Sandow JJ; Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Lewis AC; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Murphy KJ; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Kolesnikoff N; Translational Haematology Program, Peter McCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Moretti PAB; The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Cancer Division, St Vincent's Clinical School, University of NSW, Sydney, New South Wales, Australia.
  • Tea MN; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Tergaonkar V; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Timpson P; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Pitson SM; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Webb AI; Institute of Molecular and Cell Biology, A*STAR and Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Whitfield RJ; The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Cancer Division, St Vincent's Clinical School, University of NSW, Sydney, New South Wales, Australia.
  • Lopez AF; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Kochetkova M; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
  • Samuel MS; Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Nat Cell Biol ; 22(7): 882-895, 2020 07.
Article em En | MEDLINE | ID: mdl-32451439

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Moléculas de Adesão Celular / Proteínas da Matriz Extracelular / EIF-2 Quinase / Reprogramação Celular / Quinases Associadas a rho / Fibroblastos Associados a Câncer Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Moléculas de Adesão Celular / Proteínas da Matriz Extracelular / EIF-2 Quinase / Reprogramação Celular / Quinases Associadas a rho / Fibroblastos Associados a Câncer Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article